Have a say: What is your preferred way to receive policy relevant information?
In this short questionnaire we aim to identify the most suitable ways to transfer policy relevant information – the questionnaire is open until 20th March 2026.
Call for evidence for the Advanced Materials Act – MACRAMÉ provided a response
With the expertise brought together in MACRAMÉ and the experiences gained throughout the project duration, MACRAMÉ responded to the call for evidence to the Advanced Materials Act.
New Publication: Boron Nitride Nanomaterials Trigger Immunomodulatory Effects in Human Broncho-Epithelial Cells by Modulating Eicosanoid Lipid Signaling
MACRAMÉ colleagues from EMPA contributed to the publication ‘Boron Nitride Nanomaterials Trigger Immunomodulatory Effects in Human Broncho-Epithelial Cells by Modulating Eicosanoid Lipid Signaling’. For the successful commercial development of emerging 2D materials, it is crucial to understand their potential biological effects on healthy and diseased individuals.
MACRAMÉ Experts provided feedback to the SSbD Framework
MACRAMÉ Experts used the opportunity to provide feedback in the commenting phase of the revision of the Safe and Sustainable by Design Chemicals and Materials Framework.
Recap – Joint Risk Assessor Summit on Advancing Safety & Sustainability Assessments of Advanced Materials
The ‘Joint Risk Assessor Summit on Advancing Safety & Sustainability Assessments of Advanced Materials’ hosted by ACCORDs, iCARE, MACRAMÉ, and nanoPASS, was a full success. To address new challenges for safety and sustainability assessment coming with advanced materials, the EU Horizon Europe projects ACCORDs, iCARE, MACRAMÉ, and nanoPASS hosted the Read more









